A Randomized, Masked, Placebo Controlled, Phase II Trial Of Concurrent Chemoradiation With BMX-001 In Patients With Head And Neck Squamous Cell Carcinoma Receiving Concurrent Chemoradiation
Eligible for screening study DCP 001
CC013 is Open to Accrual, effective June 3, 2025, with the implementation of Amendment 1.
